Geographic expansion and regulatory expertise: With an increasingly complex global regulatory environment, biopharma ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

In this video, Tanya Dorff, MD discusses the current state of the pipeline for developing castration-resistant prostate cancer treatments.

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States Department of Chemistry and Biochemistry, University of North ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today ...

A snake catcher shared detailed warnings and a story of a Durban man who was fanged by a venomous stiletto snake. The chap ...

Copyright held by the owner/author(s).

The manuscript by Xu et al. studies the relevance of endophilin A3-dependent endocytosis and retrograde transport of immune synapse components and in the activation of cytotoxic CD8 T cells. First, ...